Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study
Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study. // Annals of Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S0923753426086448?dgcid=rss_sd_all
Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study. Annals of Oncology. https://www.sciencedirect.com/science/article/pii/S0923753426086448?dgcid=rss_sd_all
“Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study.” Annals of Oncology.
@article{article35983,
title = {Prospective circulating tumour DNA surveillance in patients with early high-risk hormone receptor positive, HER2-negative breast cancer in the TRAK-ER study},
journal = {Annals of Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S0923753426086448?dgcid=rss_sd_all}
}